The new offer is nearly $50m more than the last bid from Regeneron Pharmaceuticals, which had been declared the winner of the ...

The judge overseeing the bankruptcy of 23andMe questioned the limits proposed for a second auction that is designed to push bids higher than a current $256 million offer from Regeneron Pharmaceuticals ...

Me will hold a second auction for its DNA data with an opening bid of $305 million from former CEO Anne Wojcicki. Here's all ...

Bankrupt genetic testing firm 23andMe is seeking to reopen bidding on its assets, including over 15 million customer DNA ...

Bankrupt genetic testing company 23andMe told a U.S. bankruptcy judge on Wednesday that it wants to re-open bidding on its ...

When direct-to-consumer genetic testing company 23andMe Holding Co. and its affiliates (together, “23andMe”) filed for chapter 11 bankruptcy on ...

A judge overseeing 23andMe’s bankruptcy questioned the implications of a provision in President Donald Trump’s “big beautiful ...

Me is teetering on the edge of bankruptcy and actively seeking a buyer. That buyer, unless explicitly restricted, could gain ...

Me has filed for Chapter 11 bankruptcy protection in the U.S., which means your genetic data is for sale, and you only have ...

We’ve entered an era where biometric identity is currency. Regeneron just cornered a market without asking the public, the ...

The founder of 23andMe, Anne Wojcicki, has asked a judge to reopen an auction for the genetic testing company, saying she has ...

Regeneron Pharmaceuticals said on Monday it will buy genomics firm 23andMe Holding for $256 million through a bankruptcy ...